Ensysce Biosciences Inc (ENSC)

NASDAQ
Currency in USD
3.9000
+0.0100(+0.26%)
Closed
After Hours
3.9700+0.0700(+1.7949%)
ENSC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
3.77883.9469
52 wk Range
2.118014.6700
Key Statistics
Edit
Prev. Close
3.89
Open
3.9
Day's Range
3.7788-3.9469
52 wk Range
2.118-14.67
Volume
15.38K
Average Volume (3m)
57.05K
1-Year Change
-67.32%
Book Value / Share
2.84
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENSC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Ensysce Biosciences Inc Company Profile

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP oxycodone prodrug candidate for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF614, an extended-release oxycodone-derivative that releases clinically effective oxycodone; PF329 for pain with abuse protection; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD; and PF9001 to treat Opioid use disorder. The company was founded in 2003 and is based in La Jolla, California.

Compare ENSC to Peers and Sector

Metrics to compare
ENSC
Peers
Sector
Relationship
P/E Ratio
−0.7x−7.5x−0.5x
PEG Ratio
−0.01−0.430.00
Price/Book
1.5x−4.1x2.6x
Price / LTM Sales
1.1x48.9x3.0x
Upside (Analyst Target)
-144.8%56.4%
Fair Value Upside
Unlock14.4%9.9%Unlock

Earnings

Latest Release
May 15, 2023
EPS / Forecast
-2.08 / -5.08
Revenue / Forecast
789.60K / 950.00K
EPS Revisions
Last 90 days

FAQ

What Is the Ensysce Biosciences (ENSC) Stock Price Today?

The Ensysce Biosciences stock price today is 3.90

What Stock Exchange Does Ensysce Biosciences Trade On?

Ensysce Biosciences is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Ensysce Biosciences?

The stock symbol for Ensysce Biosciences is "ENSC."

What Is the Ensysce Biosciences Market Cap?

As of today, Ensysce Biosciences market cap is 5.48M.

What is Ensysce Biosciences Earnings Per Share?

The Ensysce Biosciences EPS is -11.45.

From a Technical Analysis Perspective, Is ENSC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.